At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PBM Psyence Biomedical Ltd
Closed 09-18 16:00:00 EDT
0.1390
+0.0140
+11.20%
盘后0.1400
+0.0010+0.72%
19:58 EDT
High0.1394
Low0.1260
Vol3.22M
Open0.1290
D1 Closing0.1250
Amplitude10.72%
Mkt Cap2.32M
Tradable Cap1.50M
Total Shares16.70M
T/O430.18K
T/O Rate29.85%
Tradable Shares10.79M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Psyence Group's Nasdaq-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
Psyence Group's Nasdaq-Listed Associate, Psyence Biomedical, Announces Initiation of First Trial Site in Australia for Its Phase Iib Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
Psyence Biomed Announces Initiation of First Trial Site in Australia for Its Phase Iib Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care
Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.